U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Use of Electronic Vapor Products Before, During, and After Pregnancy Among Women with a Recent Live Birth — Oklahoma and Texas, 2015

Supporting Files Public Domain
File Language:
English


Details

  • Journal Article:
    Morbidity and Mortality Weekly Report (MMWR)
  • Personal Author:
  • Description:
    Electronic vapor products (EVPs) comprise a diverse group of devices, including electronic cigarettes (e-cigarettes). EVP users inhale an aerosol that typically contains nicotine, flavorings, and other additives (1). Nicotine is a developmental toxicant that adversely affects pregnancy and infant outcomes (2). Data from the 2015 Pregnancy Risk Assessment Monitoring System (PRAMS) for Oklahoma and Texas were analyzed to estimate population-based EVP use among women with a recent live birth. EVP use before pregnancy (defined as >3 months before pregnancy) and around the time of pregnancy (defined as any time during the 3 months before pregnancy, the last 3 months of pregnancy, or 2-6 months after delivery), reasons for EVP use, and dual use of EVPs and cigarettes were assessed. Prevalence of EVP use was 10.4% before pregnancy and 7.0% around the time of pregnancy, including 1.4% during the last 3 months of pregnancy. Among women using EVPs during the last 3 months of pregnancy, 38.4% reported use of EVPs containing nicotine, and 26.4% were unsure of nicotine content. Among women who had used EVPs and cigarettes, dual use prevalence was 38.0% in the 3 months before pregnancy, 7.7% during the last 3 months of pregnancy, and 11.8% in the 2-6 months after delivery. The most frequently reported reasons for EVP use around the time of pregnancy were curiosity (54.0%), the perception that EVPs might help with quitting or reducing cigarette smoking (45.2%), and the perception of reduced harm to the mother, when compared with cigarette smoking (45.2%). Clear messages that EVP use is not safe during pregnancy are needed, and broad, barrier-free access to evidence-based tobacco cessation strategies need to be made available.
  • Subjects:
  • Source:
    MMWR Morbidity Mortal Weekly Rep. 68(8):189-194
  • Series:
  • DOI:
  • ISSN:
    0149-2195 (print) ; 1545-861X (digital)
  • Pubmed ID:
    30817748
  • Pubmed Central ID:
    PMC6394383
  • Document Type:
  • Place as Subject:
  • Pages in Document:
    6 pdf pages
  • Volume:
    68
  • Issue:
    8
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:206ca30879ff5f590ab49d7a34bdd66dbdeb307885d890733ef38d98f1c90056242ca4aa11a81553b2c64558dc3e9e77475148f6e2f0b7c0316b9ebee7d22d1b
  • Download URL:
  • File Type:
    Filetype[PDF - 186.13 KB ]
File Language:
English
ON THIS PAGE
 Was this page helpful?
 Found an issue?
Send us an email at:
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.